DISC-3405

· Disc Medicine, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DISC-3405, covering 2024-12-18 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) [Phase 1]